Clinical Trial Update: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

View source ↗

Summary

A post-approval registry study evaluating Exablate 4000 Type 1.0/1.1 unilateral pallidotomy for advanced idiopathic Parkinson's disease with medication-refracto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Exablate 4000

Snippet

Sponsor: InSightec | Conditions: Movement Disorders, Neurology | Status: RECRUITING